±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 523  |  »Ø¸´: 2

´å¿ÚÒ»¶×

ľ³æ (ÖøÃûдÊÖ)

ÎÞ

[ÇóÖú] ÇóÖúÒ»¶Î·­Òë

3. Drug Receptors & Pharmacodynamics
Therapeutic and toxic effects of drugs result from their interactions with molecules in the patient. Most drugs act by associating with specific macromolecules in ways that alter the macromolecules' biochemical or biophysical activities. This idea, more than a century old, is embodied in the term receptor: the component of a cell or organism that interacts with a drug and initiates the chain of events leading to the drug's observed effects.
Receptors have become the central focus of investigation of drug effects and their mechanisms of action (pharmacodynamics). The receptor concept, extended to endocrinology, immunology, and molecular biology, has proved essential for explaining many aspects of biologic regulation. Many drug receptors have been isolated and characterized in detail, thus opening the way to precise understanding of the molecular basis of drug action.
The receptor concept has important practical consequences for the development of drugs and for arriving at therapeutic decisions in clinical practice. These consequences form the basis for understanding the actions and clinical uses of drugs described in almost every chapter of this book. They may be briefly summarized as follows:
    (1) Receptors largely determine the quantitative relations between dose or concentration of drug and pharmacologic effects. The receptor's affinity for binding a drug determines the concentration of drug required to form a significant number of drug-receptor complexes, and the total number of receptors may limit the maximal effect a drug may produce.
    (2) Receptors are responsible for selectivity of drug action. The molecular size, shape, and electrical charge of a drug determine whether¾and with what affinity¾it will bind to a particular receptor among the vast array of chemically different binding sites available in a cell, tissue, or patient. Accordingly, changes in the chemical structure of a drug can dramatically increase or decrease a new drug's affinities for different classes of receptors, with resulting alterations in therapeutic and toxic effects.
    (3) Receptors mediate the actions of both pharmacologic agonists and antagonists. Some drugs and many natural ligands, such as hormones and neurotransmitters, regulate the function of receptor macromolecules as agonists; ie, they activate the receptor to signal as a direct result of binding to it. Some agonists activate a single kind of receptor to produce all of their biologic functions, whereas others selectively promote one receptor function more than another.
Other drugs act as pharmacologic antagonists; ie, they bind to receptors but do not activate generation of a signal; consequently, they interfere with the ability of an agonist to activate the receptor. The effect of a so-called "pure" antagonist on a cell or in a patient depends entirely on its preventing the binding of agonist molecules and blocking their biologic actions. Other antagonists, in addition to preventing agonist binding, suppress the basal signaling ("constitutive" activity of receptors. Some of the most useful drugs in clinical medicine are pharmacologic antagonists.

» ²ÂÄãϲ»¶

ÎÞ
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
sltmac(½ð±Ò+1): »¶Ó­½»Á÷~ 2011-07-05 08:42:23
Õâ¸öûʲôÄѶȰ¡£¬Ö»ÊÇÌ«³¤¡£Ö»°ÑÄãÓÐÎÊÌâµÄ¾ä×ÓÌô³öÀ´£¬Èôó¼ÒÌÖÂÛºÃÂð£¿×÷ÒµÖ÷Òª»¹ÊÇ×Ô¼ºÐ´£¬ÕâÑù²ÅÊǹÔѧÉú°¡
2Â¥2011-07-01 11:41:34
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

LittleBush

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡ï
sltmac(½ð±Ò+1): ¸Ðл½»Á÷~~ 2011-07-04 08:11:26
Actually,there in no obstacleis in understanding the posted thread and it is very common knowledge pertaining to pharmacology.I agree with the above on that you should do your homework yourself.If you are a graduate student,then developing the ability to reading English literature is a basic and essential skill you must learn well.
3Â¥2011-07-01 12:38:30
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ´å¿ÚÒ»¶× µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÏÃÃÅ´óѧ£¬ÉúÎïÓëÒ½Ò©£¬×Ü·Ö272£¬±¾¿Æ211 +6 Electron1cc 2026-04-01 7/350 2026-04-07 13:19 by guanxin1001
[¿¼ÑÐ] 22408 318·ÖÇóµ÷¼Á +3 ÇڷܵÄСÁý°ü 2026-04-06 4/200 2026-04-07 13:12 by ¶¡ìÇoye
[¿¼ÑÐ] 285Çóµ÷¼Á +9 AZMK 2026-04-05 14/700 2026-04-07 13:01 by Sammy2
[¿¼ÑÐ] 297·Ö083200ÇóÖú +9 aekx 2026-04-05 9/450 2026-04-06 20:57 by flysky1234
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +10 cs0106 2026-04-05 12/600 2026-04-06 19:41 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »úеר˶274Çóµ÷¼Á£¬²»ÌôרҵѧУ +6 ·º·º2333 2026-04-05 8/400 2026-04-06 18:06 by ·º·º2333
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-05 4/200 2026-04-06 12:29 by ÖзÉÔº¿Õ¹ÜѧԺÑ
[¿¼ÑÐ] 262Çóµ÷¼Á +7 ÌìϵÚÒ»ÎÄ 2026-04-04 8/400 2026-04-05 21:31 by ¼¤Á÷Ó¶É
[¿¼ÑÐ] 326Çóµ÷¼Á +3 ¹ËÈô¸¡Éú 2026-04-05 3/150 2026-04-05 18:32 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 348Çóµ÷¼Á +6 wukira 2026-04-04 6/300 2026-04-05 18:11 by Öí»á·É
[¿¼ÑÐ] 282Çóµ÷¼Á +7 aaa³µÁ¾ 2026-04-02 11/550 2026-04-05 17:24 by yulian1987
[¿¼ÑÐ] ²ÄÁÏר˶ µ÷¼Á +14 CXN123456 2026-04-03 14/700 2026-04-05 17:18 by Hdyxbekcb
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á +12 ²×º£ÇáÖÛe 2026-04-03 13/650 2026-04-04 23:45 by lqwchd
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +15 Ò»ÑùYWY 2026-04-01 15/750 2026-04-04 22:23 by hemengdong
[¿¼ÑÐ] 342Çóµ÷¼Á +3 Liang7111 2026-04-04 5/250 2026-04-04 19:47 by dongzh2009
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +7 ÏàÐűػá¹ââÍòÕ 2026-04-02 7/350 2026-04-03 16:48 by rzh123456
[¿¼ÑÐ] Çóµ÷¼Á»ú»á +5 ÒâȾivy 2026-04-03 5/250 2026-04-03 15:13 by qoooooo614
[¿¼ÑÐ] Çóµ÷¼Á22408 288·Ö +5 new382 2026-04-02 5/250 2026-04-03 09:13 by ×íÔÚ·çÀï
[¿¼ÑÐ] 298ÇóBÇøµ÷¼Á +4 zzz£¬£¬r 2026-04-02 5/250 2026-04-02 12:17 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +11 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 11/550 2026-04-02 10:52 by lnilvy
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û